CIARDULLO STEFANO

Ciardullo, S., Morieri, M., Daniele, G., Fiorentino, T., Mezza, T., Tricò, D., et al. (2024). GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes. ACTA DIABETOLOGICA [10.1007/s00592-024-02300-6]. Dettaglio

Ciardullo, S. (2024). The MAFLD‐MASLD debate: Does cardiovascular risk prediction define the winner?. LIVER INTERNATIONAL, 44(7 (July 2024)), 1564-1566 [10.1111/liv.15950]. Dettaglio

Ciardullo, S., Perseghin, G. (2024). Steatotic Liver Disease Phenotypes in the United States: The Impact of Alcohol Consumption Assessment. JOURNAL OF HEPATOLOGY, 80(5 (May 2024)), 203-204 [10.1016/j.jhep.2023.09.023]. Dettaglio

Ciardullo, S., Dodesini, A., Lepore, G., Corsi, A., Scaranna, C., Perseghin, G., et al. (2024). Development of a new model of insulin sensitivity in patients with type 2 diabetes and association with mortality. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 109(5 (May 2024)), 1308-1317 [10.1210/clinem/dgad682]. Dettaglio

Ciardullo, S., Mantovani, A. (2024). Resmetirom for the treatment of nonalcoholic steatohepatitis: Evaluating the robustness of available evidence. DIGESTIVE AND LIVER DISEASE [10.1016/j.dld.2024.03.009]. Dettaglio